ScholarIQanswers from OpenAlex
National Institute for Health and Care Research
FunderResearch funding and supported work
National Institute for Health and Care Research is a funder indexed in ScholarIQ from OpenAlex.
What is known about National Institute for Health and Care Research?
ScholarIQrecord summary
research organisation in health and care in the United Kingdom
How many works does National Institute for Health and Care Research have?
ScholarIQindexed works
National Institute for Health and Care Research has 211,188 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for National Institute for Health and Care Research?
ScholarIQopenalex
The OpenAlex for National Institute for Health and Care Research is on the source record.
What is the ROR of National Institute for Health and Care Research?
ScholarIQror
The ROR for National Institute for Health and Care Research is on the source record.
What are the most-cited papers on National Institute for Health and Care Research?
ScholarIQmost cited works
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Frank Bridoux, Kelly A. Burdge, Tak Mao Chan, H. Terence Cook, Fernando C. Fervenza, Keisha L. Gibson, Richard J. Glassock, David Jayne, Vivekanand Jha, Adrian Liew, Zhi-Hong Liu, Juan M. Mejía‐Vilet, Carla Nester, Jai Radhakrishnan, Elizabeth M. Rave, Heather N. Reich, Pierre Ronco, Jan‐Stephan Sanders, Sanjeev Sethi, Yusuke Suzuki, Sydney Tang, Vladimı́r Tesař, Marina Vivarelli, Jack F.M. Wetzels, Lyubov Lytvyn, Jonathan C. Craig, David J. Tunnicliffe, Martin Howell, Marcello Tonelli, Michael Cheung, Amy Earley, Jürgen Floege
The frequency and outcome of lupus nephritis: results from an international inception cohort study
John G. Hanly, Aidan G. O’Keeffe, Li Su, Murray B. Urowitz, Juanita Romero‐Díaz, Caroline Gordon, Sang‐Cheol Bae, Sasha Bernatsky, Ann E. Clarke, Daniel J. Wallace, Joan T. Merrill, David Isenberg, Anisur Rahman, Ellen M. Ginzler, Paul R. Fortin, Dafna D. Gladman, Jorge Sánchez‐Guerrero, Michelle Petri, Ian N Bruce, Mary Anne Dooley, Rosalind Ramsey‐Goldman, Cynthia Aranow, Graciela S. Alarcón, Barri J. Fessler, Kristján Steinsson, Ola Nived, Gunnar Sturfelt, Susan Manzi, Munther A. Khamashta, Ronald van Vollenhoven, Asad Zoma, Manuel Ramos‐Casals, Guillermo Ruiz‐Irastorza, S. Sam Lim, Thomas Stoll, Murat İnanç, Kenneth Kalunian, Diane L. Kamen, Peter J. Maddison, Christine Peschken, Søren Jacobsen, Anca Askanase, Chris Theriault, Kara Thompson, Vernon T. Farewell
Air Pollution and Dementia: A Systematic Review
Ruth Peters, Nicole Ee, Jean Peters, Andrew Booth, Ian Mudway, Kaarin J. Anstey
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
Rajiv Agarwal, Patrick Rossignol, Alain Romero, Dahlia Garza, Martha Mayo, Suzette Warren, Jia Ma, William B. White, Bryan Williams
Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease
Nicola C. Edwards, Richard P. Steeds, Paul M. Stewart, Charles J. Ferro, John Townend